Diagnostyka i leczenie raka piersi FALENTY 2019 Diagnosis and Treatment of Breast Cancer FALENTY st Polish American Conference

Transkrypt

1 CONFERENCE PROGRAMME Diagnostyka i leczenie raka piersi FALENTY 2019 Diagnosis and Treatment of Breast Cancer FALENTY st Polish American Conference April 11 13, 2019 WARSAW PLAZA H*O*T*E*L 8:00 10:00 BREAST CANCER DATA BASE WORKING GROUP MEETING Thursday, 11th April 2019 Room A Room B 10:15 12:00 Plenary Session Chairs: Prof. Tadeusz Pieńkowski, Prof. Katherine H.R. Tkaczuk, Prof. Marek Wojtukiewicz 10:15 10:30 Diplomas for new accredited Breast Cancer Centers: Szczecin, Warszawa, Opole Prof. Ruben Orda, Prof. Alexander Mundinger, Prof. Tadeusz Pieńkowski 10:30 11:00 Recent advances in breast cancer treatment Prof. Dennis Slamon 11:00 11:30 Clinical Utility of Multigene Panel Testing in management of breast cancer Dr Paula Rosenblatt 11:30 12:00 Evolution of the philosophy in breast cancer treatment Prof. Jacek Jassem 12:00 13:00 Lunch 13:00 14:30 Session IA GENETIC COUSELING FOR BREAST CANCER PATIENT Workshop 13:00 14:30 Session IB DIAGNOSIS & SCREENING OF BREAST CANCER Workshop Prof. Jan Lubiński, Dr Suliat Nurudeen, Dr Paula Rosenblatt Dr Cristina Campassi, Prof. Alexander Mundinger 13:00 13:25 Who needs Genetic Counseling, review of guidelines Prof. Jan Lubiński 13:25 13:50 Chemoprevention for high risk individuals examining the evidence Dr Paula Rosenblatt 13:50 14:15 Surgical risk reduction in genetic mutation carriers Dr Suliat Nurudeen 14:15 14:30 QA 14:30 15:00 Coffee break 13:00 13:25 Case 1: Imaging Strategies in women with dense breasts Dr. Cristina Campassi 13:25 13:50 Case 2: Screening Mammography-benefits of tomosynthesis Prof. Elżbieta Łuczyńska 13:50 14:15 Case 3: Risk stratified screening of breast cancer including MRI Prof. Alexander Mundinger 14:15 14:30 QA

2 15:00 16:30 Session IIA SYSTEMIC TREATMENT OF EARLY STAGE BREAST CANCER Workshop. Case. / Lecture Presentation Prof. Katherine H. R. Tkaczuk, Prof. Maria Litwiniuk 15:00 15:25 Case1 Neoadjuvant chemotherapy approaches & breast cancer subtypes? Dr Wojciech Olszewski 15:25 15:50 Case2 Adjuvant Therapy for HER2+ Breast Cancer Prof. Renata Duchnowska 15:50 16:15 Case3 Adjuvant Endocrine Therapy Prof. Maria Litwiniuk 16:15-16:30 QA 16:30 17:30 Coffee break 15:00 16:30 Session IIB SURGIGAL TREATMENT OF BREAST CANCER Workshop Case/Lecture Presentation Dr Suliat Nurudeen, Prof. Agnieszka Kołacińska 15:00 15:25 Case 1: Management of the axilla Prof. Dawid Murawa 15:25 15:50 Case 2: Management of ADH/ALH/LCIS Dr Diana Hodorowicz Zaniewska 15:50 16:15 Case 3: Management of DCIS Dr Suliat Nurudeen 16:15 16:30 QA PRASKA Room 16:00 18:00 PANEL DYSKUSYJNY Współpraca radiologa i patologa w diagnostyce raka piersi w Breast Units. Dyskusja na temat korelacji radiologiczno patologicznych przypadków z biopsji piersi. Prelegenci: Dr n. med. Małgorzata Stusińska & Dr Ewa Śrutek Centrum Onkologii w Bydgoszczy Dr Magdalena Salamaga & Dr hab. n. med. Andrzej Kram Zachodniopomorskie Centrum Onkologii Dr n. med. Diana Hodorowicz Zaniewska & Dr n. med. Joanna Szpor Szpital Uniwersytecki w Krakowie Dyskusja prowadzona przez ekspertów z dziedziny radiologii i patologii: Prof. Elżbietę Łuczyńską i Prof. Jana Lubińskiego 17:30 19:00 Session IIIA SYSTEMIC TREATMENT OF ADVANCED BREAST CANCER Case/Lecture Presentation Dr Barbara Radecka, Prof. Tadeusz Pieńkowski 17:30 17:55 Case1: CD4/6-Kinase Inhibitors Hormone Receptor positive breast cancer Dr Barbara Radecka 17:55 18:20 Case2: Triple Negative Brest Cancer Dr Agnieszka Jagiełło-Gruszfeld 17:30 19:00 Session IIIB REHABILITATION AND SURVIVORSHIP Case/Lecture Presentation Dr Paula Rosenblatt, Dr Hanna Tchórzewska-Korba 17:30 17:55 Case 1: Lymphedema Management Dr Hanna Tchórzewska Korba 17:55 18:20 Case 2: Scalp Cooling Dr Paula Rosenblatt 18:20 18:45 Case 3: Survivorship Plans Dr Hanna Tchórzewska Korba 18:20 18:45 Value of health and modern therapies in breast cancer Dr Beata Jagielska 18:45 19:00 QA 18:45 19:00 QA 19:00 21:00 OPENING CEREMONY OF THE "FALENTY 2019" CONFERENCE

3 Friday, 12th April 2019 PRASKA Room 8:00 9:00 Moderator: Prof. Tadeusz Pieńkowski Dr Barbara Radecka Spotkanie z ekspertem Room A Room B 9:00 11:00 Plenary Session IV Prof. Katherine H.R. Tkaczuk, Prof. Tadeusz Pieńkowski 9:00 9:30 Recent Progress of the treatment of ER positive breast cancer Prof. Dennis Slamon 9:30 10:00 Place of the Immunotherapy in Breast Cancer treatment Prof. Katherine H.R. Tkaczuk 10:00 10:30 HER2+ Breast Cancer Past Present Future? Prof. Joseph Gligorow 10:30 11:00 Neoadjuvant treatment of the HER2 positive breast cancer Prof. Tadeusz Pieńkowski 11:00 11:15 Coffee break 11:15 13:30 Session V HUMANISTIC AND ETHICAL SESSION Prof. Barbara Czerska Pieńkowska 13:30 14:30 Lunch 14:30 15:30 ACREDITED BREAST CANCER UNITS MEETING - KIER Room ROOM A 14:30 16:00 Session VIA Multidisciplinary Case Conference Workshop Discussion/MultiD- Panel Dr Elizabeth Nichols, Dr Małgorzata Talerczyk 14:30 14:55 Case 1: DCIS Dr Suliat Nurudeen 14:55 15:20 Case 2: Stage II breast cancer Dr Paula Rosenblatt 5:20 15:45 Case 3: Stage III breast Cancer Dr Elizabeth Nichols ROOM B 14:30 16:00 Session VIB Management of Toxicities of Systemic Therapies (cardiac and others) Workshop Dr hab. Sebastian Szmit, Dr Maria Górnaś 14:30 14:55 Cardiac Toxicities of Breast Cancer Therapies (Radiation & Systemic) Prof. Sebastian Szmit 14:55 15:20 Toxicities of systemic therapies- MTOR, CD 4/6 kinase and PARP inhibitors Dr Maria Górnaś 15:20 15:45 Neurological Toxicities-PSN, chemobrain? Study Dr Halina Rudnicka 14:30 15:00 PRASKA ROOM Bo doświadczenie ma znaczenie Leki biopodobne w leczeniu raka piersi Dr Agnieszka Jagiełło Gruszfeld

4 15:45 16:00 QA 15:45 16:00 QA 16:00 17:30 Session VIIA SURGERY WORKSHOP Surgical treatment of breast cancer Dr Suliad Nurudeen Prof. Dawid Murawa 16:00 16:25 Case 1: Contralateral Prophylactic Mastectomy Dr Diana Hodorowicz Zaniewska 16:25 16:50 Case 2: Management of Loco/regional Recurrence Dr Monika Nagadowska 16:50 17:15 Case 3: Surgery for Metastatic Disease, when is it applicable Dr Suliat Nurudeen 17:15 17:30 QA 17:30 17:45 Coffee break 16:00 17:30 Session VIIB RADIOTHERAPY WORKSHOP Radiotherapy in treatment of breast cancer Dr Elizabeth Nichols, Prof. Barbara Jereczek Fossa 16:00 16:10 Zastosowanie ABC u kobiet po lewostronnej mastektomii w celu obniżenia dawki na serce w trakcie radioterapii uzupełniającej Dr Kamil Majbrodzki 16:10 16:20 Czy zastosowanie ABC u kobiet po leczeniu oszczędzającym lewej piersi ma wpływ na obniżenie dawki na serce i płuca w trakcie radioterapii Dr Katarzyna Majbrodzka 16:20 16:45 Case: Proton Therapy Dr Elizabeth Nichols 16:45 17:15 Breast radiotherapy: one size fits all is not true anymore Prof. Barbara Jereczek Fossa 17:15 17:30 QA 15:30 17:00 PRASKA Room Debate: Whether and how we can optimize treatment of HER2+ ebc in Poland? Chairman: Prof. Tadeusz Pieńkowski Speakers: HER2+ ebc treatment how and why to do it in Europe Prof. Gligorov Joseph ebc neoadjuvant treatment in high risk group of patients clinical experience Dr Agnieszka Jagiełło Gruszfeld ebc adjuvant treatment in high risk group of patients clinical experience Dr Barbara Radecka Debate with the panel of Experts 17:45 18:30 Session VIII A RECONSTRUCTION AND PROPHYLAXIS SURGERY Prof. Zoran Stojcev, Dr Sławomir Mazur, Dr Tadeusz Witwicki 17:45 18:30 WILANOWSKA ROOM Breakthrough Advanced Breast Cancer HR+, HER2- Therapy in Clinical Practice Dr Agnieszka Jagiełło - Gruszfeld Speakers: 17:45 18:00 Own experience in the treatment of Ribociclib in Advanced Breast Cancer Patients HR+, HER2- Dr n. med. Ewa Chmielowska 18:00 18:15 Clinical cases of Advanced Breast Cancer Patients HR+, HER2- treated with Ribociclib therapy Dr n. med. Michał Jarząb 18:15 18:30 Management of ABC HR+, HER2- patients on combination therapy with Ribociclib from own experience Dr Roman Dubiański 18:30 POLISH SOCIETY FOR BREAST CANCER RESEARCH GENERAL MEMBERS MEETING KIER Room 20:30 5 YEARS OF ACTIVITY OF ACCREDITED BCU CENTERS IN POLAND SUMMARY AND PLANS FOR FURTHER DEVELOPMENT

5 Saturday, 13th APRIL 2019 Room A Room B 9:00 11:00 Session IX BREAST CANCER UNIT FROM THEORY TO PRACTICE Dr med. Małgorzata Talerczyk, Prof. Tadeusz Pieńkowski 9:00 9:20 BCU Szczecin Dr Michał Falco 9:20 9:40 BCU Bydgoszcz: Tumour laterality as a possible prognostic factor for invasive breast cancer patients Dr n med. Piotr Rhone 9:40 10:00 BCU Gdynia: How have the oncoplastic and reconstructive technics changed surgical approach to the breast cancer treatment in Gdynia Breast Cancer Unit? Dr n med. Jacek Wydra 10:00-10:15 BCU Kraków Dr Joanna Streb 10:15 10:25 BCU Opole Dr n med. Barbara Radecka 10:25 10:40 BCU Kielce: Radioterapia po mastektomii podskórnej z jednoczasową rekonstrukcją za pomocą protezy. Dr n med. Piotr Kędzierawski 10:40 10:50 BCU Warszawa Dr hab. n med. Renata Duchnowska 10:50 11:00 BREAST CANCER UNIT FROM THEORY TO PRACTICE Closing and remarks 11: Breast cancer index how we can monitor effectiveness and quality of care between the countries regions and centers Jakub Gierczyński 11:20 11:30 Coffee break 11:30 12:00 Session X BREAST CANCER SURGERY GUIDELINESS (NOT ONLY FOR SURGERONS) Prof. Agnieszka Kołacińska, Dr Suliat Nurudeen, Prof. Zoran Stojcev 12:00 12:30 Session XI ADJUVANT RADIATION TREATMENT GUIDELINESS BENEFITS AND RISKS Dr Elizabeth Nichols, Dr Michał Falco

6 12:30 13:00 Session XII HORMONAL THERAPY TREATMENT GUIDELINESS ADJUVANT AND ADVANCED Prof. Maria Litwiniuk, Prof. Marek Wojtukiewicz The new look of classic therapy is it the time to change the standard? Dr Iwona Głogowska 13:00 13:30 Session XIII HER2 POSITIVE BREAST CANCER TREATMENT GUIDELINESS NEOADJUVANT, ADJUVANT AND ADVANCED Prof. Renata Duchnowska, Prof Katherine H.R. Tkaczuk 13:30 14:00 CLOSING REMARKS Prof. Tadeusz Pieńkowski, Prof. Katherine H. R. Tkaczuk, Prof. Marek Wojtukiewicz 14:00 Lunch

7 SPONSOR STRATEGICZNY SPONSOR SPONSOR WSPIERAJĄCY PATRONAT NASI PARTNERZY

8 Conference office: Marta Stankiewicz Delta Tour Sp. z o.o. konferencja@konferencjafalenty.pl Conference organizer: Polish Society on Breast Cancer Research kontakt@rakpiersi.org.pl